TENX

Tenax Therapeutics Inc

NASDAQ: TENX · HEALTHCARE · BIOTECHNOLOGY

$1.88

+9.30% today

Updated 2026-10-28

Market cap

$61.38M

P/E ratio

—

P/S ratio

414.72x

EPS (TTM)

$-1.48

Dividend yield

—

52W range

$1 – $19

Volume

4.0M

Market cap

$61.38M

P/E ratio

—

P/S ratio

414.72x

EPS (TTM)

$-1.48

Dividend yield

—

52W range

$1 – $19

Volume

4.0M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

4.3

Growth

6.3

Quality

3.0

Profitability

5.3

Valuation

C+

1/9

Piotroski F-Score

Weak

2.7

Altman Z-Score

Grey zone

—

Industry rank

—

View all highly rated stocks (75+) →271 stocks currently score above 75

Price targets

Analyst target

$9.62

+411.70%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy5 Buy4 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-14.15M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-11.05M	$-7.71M	$-17.60M	$-52.60M	$-17.80M
EPS	—	—	—	—	$-1.48
Free cash flow	$-12.02M	$-5.91M	$-14.81M	$-35.80M	$-14.15M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-07-13	GIORDANO, CHRISTOPHER THOMAS	Sale	8,500	—
2026-07-13	GIORDANO, CHRISTOPHER THOMAS	Sale	219	—
2026-07-13	GIORDANO, CHRISTOPHER THOMAS	Buy	8,500	$5.94

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TENX	$61.38M	40	4.3	3.0	5.3	6.3	—	Hold
LLY	$1.12T	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$615.87B	57	4.7	8.5	2.7	5.5	-83.05%	Buy
ABBV	$504.37B	73	6.7	8.5	4.0	5.0	-86.73%	Strong Buy
UNH	$360.32B	62	6.7	6.0	4.7	5.5	-25.92%	Buy
MRK	$360.08B	36	4.0	4.5	2.0	5.0	-73.68%	Hold

Smart narrative

Tenax Therapeutics Inc trades at $1.88. Our Smart Value Score of 40/100 indicates the stock is fair. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 2.66, it sits in the grey zone.

Frequently asked questions

What is Tenax Therapeutics Inc's stock price?

Tenax Therapeutics Inc (TENX) trades at $1.88, on a P/S of 414.7x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is Tenax Therapeutics Inc overvalued?

Tenax Therapeutics Inc carries a Smart Value Score of 40/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Tenax Therapeutics Inc (TENX)?

The 12-month analyst consensus target is $9.62, about 411.7% above the current $1.88. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Tenax Therapeutics Inc's Altman Z-Score is 2.66, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.tenaxthera.com

Quick metrics

P/S ratio414.72x

ROE-50.49%

Beta0.92

50D MA$1.84

200D MA$10.34

Shares out0.04B

Float0.03B

Short ratio—

Avg volume4.0M

Performance

1 week-90.05%

1 month-92.17%

3 months-88.70%

YTD-88.72%

1 year—

3 years—

5 years—

Compare

TENX vs LLY →TENX vs JNJ →TENX vs ABBV →Stock screener →